Biopool Gets FDA’s OK to Market New Line
- Share via
Biopool International Inc., a Ventura producer of medical test kits, has received federal Food and Drug Administration approval to market a new lilene of controls used in drug abuse testing.
The new line includes seven different controls for a total of 10 drugs commonly used in random testing, pre-employment screening and the testing of persons in parole and probation programs.
Michael D. Bick, Biopool’s chairman and chief executive, said such controls, which verify a test’s accuracy, represent a $30-million U.S. market and a $60-million worldwide market.
Biopool, founded in 1987, now produces about 40 tests and controls, mostly for diagnosing bleeding and vascular disorders.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
